Jirka Taylor

Photo of Jirka Taylor
Policy Analyst
Washington Office


M.Phil. in international relations, University of Cambridge; M.A. in American studies, Charles University, Prague; B.A. in international area studies, Charles University, Prague

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts


Jirka Taylor is a policy analyst at the RAND Corporation. He works in the area of criminal justice and social policy. His research interests include licit and illicit drug markets, community safety, and social and health policy interventions. He frequently works on evaluations, impact assessments, and cost analyses.

While at RAND, Taylor has worked on a number of mixed-method evaluations and assessments of criminal justice and social policy interventions. Recent examples include a study on heroin-assisted treatment and supervised consumption sites, an assessment of existing and potential EU measures in the fight against corruption, and an evaluation of policing in New York City. Other examples of Taylor's portfolio include an NIJ-funded study exploring the relationship between online hate speech and offline hate crimes and a comparative international study on criminal history record systems sponsored by the BJS. Taylor has also co-authored a series of studies on topics related to people’s experience and interaction with the criminal justice system, including a review of the effectiveness of mentoring interventions in prisons and an international study on procedural rights and detention conditions.

Before joining RAND, Taylor worked as an intern for the Broadcasting Board of Governors and for the office of the president at Radio Free Europe/Radio Liberty. He received his M.A. in American studies from the Faculty of Social Sciences, Charles University, Prague, and his M.Phil. in international relations from the University of Cambridge. 


Czech, Slovak, French, German, Spanish


  • Fentanyl in a vial, photo by designer491/Getty Images

    What Will the Opioid Crisis Look Like in Five Years?

    Evidence suggests that once a synthetic opioid like fentanyl becomes dominant in a drug market, it stays that way. With that in mind, the United States should prepare for these drugs as a lasting phenomenon.

    Nov 18, 2019 Concord Monitor in New Hampshire

  • A man tests Estonia's internet voting system in Tallinn, February 19, 2007

    Online Voting: The Solution to Declining Political Engagement?

    The potential benefits of online voting merit a conversation across Europe about its increased use in elections. But the evidence is mixed on whether online voting actually helps increase voter turnout.

    Mar 23, 2018 E!Sharp

  • European budget

    Does the Annual Growth Survey Actually Make a Difference to EU Member States?

    Much of the European Union (EU) budget follows Annual Growth Survey (AGS) priorities, but member states' budgets do not necessarily follow the country-specific recommendations. Doing so and addressing wider concerns about the AGS could help the EU and member states identify the benefits of the AGS.

    Nov 21, 2017 E!Sharp

  • A memorial stone for the Schengen Agreement is seen in the small village of Schengen, Luxembourg January 27, 2016

    Why Re-Establishing Border Controls in Europe Could Come at a High Cost

    Reversing the Schengen agreement would come at a high economic cost, while undoing many of the positive social and political developments of the past decade.

    Oct 13, 2016 E!Sharp

  • Antibiotic syringe near a quail cage in partridge farm

    Why the United Nations General Assembly Session on Antimicrobial Resistance Matters

    Many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. The fact that world leaders are using the UN as a forum for discussions about AMR is a promising move toward developing a coordinated global plan.

    Sep 19, 2016 The RAND Blog

  • Two scientists in protective gear working in a microbiology laboratory

    European and American Efforts to Tackle AMR: Great Minds Think Alike (Almost Always)

    The U.S. and the EU are committed to tackling antimicrobial resistance. Their efforts share objectives around key areas for improvement, such as the stewardship of existing antimicrobials, surveillance of their use, and development of new antimicrobials.

    Aug 19, 2016 The Health Care Blog

  • Ukraine's Olympic rowers training in Rio de Janeiro, Brazil, July 26, 2016

    The Rio Olympics Are the Site of a Battle Against 'Super Bacteria'

    Brazilian scientists detected drug-resistant bacteria growing off some of Rio de Janeiro's beaches, close to where it will host sailing and wind-surfing events, and in the lagoon where the rowing and canoeing events will take place.

    Jul 29, 2016 Medical Xpress

  • Hereford cattle eating at a trough

    The Global Economic Costs of Antimicrobial Resistance

    In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment.

    May 20, 2016 Cultures Magazine

  • A world map shaped with pharmaceutical drugs

    The O'Neill Review: A Critical Step in Taking Global Action Against AMR

    The O'Neill Review aims to increase global knowledge of antimicrobial resistance (AMR) and generate international consensus about the nature of the problem and the necessary steps to tackle it. A RAND Europe analysis of the potential economic costs of AMR contributed to the Review.

    May 19, 2016 The RAND Blog

  • Girl holding balloons

    Does Increased Social Spending Lead to Better Population Health?

    Higher levels of social spending are strongly associated with better health outcomes in many countries, with this link strengthening over time. The association also holds when looking at regional differences within the United States, where spending varies state-by-state.

    May 11, 2016 The RAND Blog

  • An envelope full of 500 euro notes

    The True Economic Cost of Corruption in Europe: Up to €990 Billion Annually

    Corruption costs Europe up to €990 billion in GDP annually, according to a new study. That's more than eight times previous estimates.

    Mar 22, 2016 E!Sharp

  • A green bacteria colony

    The Cost of Resistance and the Attack of the Microbes

    If left unaddressed, the threat posed by antimicrobial resistance and the rise of 'superbugs' could devastate the world economy and pose a deadly threat to humanity.

    Aug 7, 2015 LifeZette

  • A scientist wearing a respirator while looking at a Petri dish

    G7 Leaders to Discuss Threat of Antimicrobial Resistance

    The threat of drug resistance can be tackled with the right set of actions, including the development of new antimicrobial drugs and alternative therapies to disrupt the rise in resistance. German Chancellor Merkel has emphasized the importance of a joint global action plan for addressing this growing problem.

    Jun 8, 2015 The RAND Blog

  • High-resolution 3D rendering of bacteria under a scanning microscope

    Ringing the Alarm Bell for Antimicrobial Resistance

    The increase in the number of bacterial and viral infections that are resistant to antimicrobial drugs poses a growing global health threat.

    Feb 20, 2015 The RAND Blog

  • American pharmacist with senior woman in pharmacy

    The Most Dangerous Mistake You Can Make During Flu Season

    Despite public awareness campaigns in the United States and Europe, many people persist in the mistaken belief that antibacterial drugs — like amoxicillin and azithromycin — are the best treatment for flu. And many doctors simply surrender when patients demand them, ignoring the scientific and medical truth: when treating the flu, antibacterial drugs just don't work.

    Oct 28, 2013 Reuters, The Great Debate blog

  • viruses and bacteria under a microscope

    Who Killed Mrs X? The Global Threat of Antimicrobial Resistance

    Antimicrobial drugs are no longer working as they once did. The bugs that they are supposed to attack are becoming increasingly resistant. Microbes follow the same rules of evolution as we do. Through reproduction and natural selection the fittest survive.

    Sep 18, 2013 The RAND Blog